Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23


CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies.

Green DJ, O'Steen S, Lin Y, Comstock ML, Kenoyer AL, Hamlin DK, Wilbur DS, Fisher DR, Nartea M, Hylarides MD, Gopal AK, Gooley TA, Orozco JJ, Till BG, Orcutt KD, Wittrup KD, Press OW.

Blood. 2018 Feb 8;131(6):611-620. doi: 10.1182/blood-2017-09-807610. Epub 2017 Nov 20.


Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.

O'Steen S, Green DJ, Gopal AK, Orozco JJ, Kenoyer AL, Lin Y, Wilbur DS, Hamlin DK, Fisher DR, Hylarides MD, Gooley TA, Waltman A, Till BG, Press OW.

Cancer Res. 2017 Jul 15;77(14):3885-3893. doi: 10.1158/0008-5472.CAN-17-0082. Epub 2017 May 31.


Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.

Green DJ, Frayo SL, Lin Y, Hamlin DK, Fisher DR, Frost SH, Kenoyer AL, Hylarides MD, Gopal AK, Gooley TA, Orozco JJ, Till BG, O'Steen S, Orcutt KD, Wilbur DS, Wittrup KD, Press OW.

Cancer Res. 2016 Nov 15;76(22):6669-6679. doi: 10.1158/0008-5472.CAN-16-0571. Epub 2016 Sep 2.


Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.

Orozco JJ, Kenoyer A, Balkin ER, Gooley TA, Hamlin DK, Wilbur DS, Hylarides MD, Frost SH, Mawad R, O'Donnell P, Sandmaier BM, Fuchs EJ, Luznik L, Green DJ, Gopal AK, Press OW, Pagel JM.

Blood. 2016 Jan 21;127(3):352-9. doi: 10.1182/blood-2014-12-617019. Epub 2015 Nov 17.


Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.

Frost SH, Frayo SL, Miller BW, Orozco JJ, Booth GC, Hylarides MD, Lin Y, Green DJ, Gopal AK, Pagel JM, Bäck TA, Fisher DR, Press OW.

PLoS One. 2015 Mar 18;10(3):e0120561. doi: 10.1371/journal.pone.0120561. eCollection 2015.


Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.

Green DJ, Shadman M, Jones JC, Frayo SL, Kenoyer AL, Hylarides MD, Hamlin DK, Wilbur DS, Balkan ER, Lin Y, Miller BW, Frost SH, Gopal AK, Orozco JJ, Gooley TA, Laird KL, Till BG, Bäck T, Sandmaier BM, Pagel JM, Press OW.

Blood. 2015 Mar 26;125(13):2111-9. doi: 10.1182/blood-2014-11-612770. Epub 2015 Jan 27.


Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.

Orozco JJ, Balkin ER, Gooley TA, Kenoyer A, Hamlin DK, Wilbur DS, Fisher DR, Hylarides MD, Shadman M, Green DJ, Gopal AK, Press OW, Pagel JM.

PLoS One. 2014 Dec 2;9(12):e113601. doi: 10.1371/journal.pone.0113601. eCollection 2014.


In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model.

Balkin ER, Kenoyer A, Orozco JJ, Hernandez A, Shadman M, Fisher DR, Green DJ, Hylarides MD, Press OW, Wilbur DS, Pagel JM.

Cancer Res. 2014 Oct 15;74(20):5846-54. doi: 10.1158/0008-5472.CAN-14-0764. Epub 2014 Sep 26.


A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

Green DJ, Orgun NN, Jones JC, Hylarides MD, Pagel JM, Hamlin DK, Wilbur DS, Lin Y, Fisher DR, Kenoyer AL, Frayo SL, Gopal AK, Orozco JJ, Gooley TA, Wood BL, Bensinger WI, Press OW.

Cancer Res. 2014 Feb 15;74(4):1179-89. doi: 10.1158/0008-5472.CAN-13-1589. Epub 2013 Dec 26.


Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.

Orozco JJ, Bäck T, Kenoyer A, Balkin ER, Hamlin DK, Wilbur DS, Fisher DR, Frayo SL, Hylarides MD, Green DJ, Gopal AK, Press OW, Pagel JM.

Blood. 2013 May 2;121(18):3759-67. doi: 10.1182/blood-2012-11-467035. Epub 2013 Mar 7.


A robust method for the preparation and purification of antibody/streptavidin conjugates.

Hylarides MD, Mallett RW, Meyer DL.

Bioconjug Chem. 2001 May-Jun;12(3):421-7.


Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.

Axworthy DB, Reno JM, Hylarides MD, Mallett RW, Theodore LJ, Gustavson LM, Su F, Hobson LJ, Beaumier PL, Fritzberg AR.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1802-7.


Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugate.

Hylarides MD, Wilbur DS, Reed MW, Hadley SW, Schroeder JR, Grant LM.

Bioconjug Chem. 1991 Nov-Dec;2(6):435-40.


Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab.

Wilbur DS, Hadley SW, Grant LM, Hylarides MD.

Bioconjug Chem. 1991 Mar-Apr;2(2):111-6.


Radiolabeling of a monoclonal antibody with N-succinimidyl para-[77Br]bromobenzoate.

Wilbur DS, Hylarides MD.

Int J Rad Appl Instrum B. 1991;18(3):363-5.


Inhibitors of sterol synthesis. Metabolism of [2,4-3H]5 alpha-cholest-8(14)-en-3 beta-ol-15-one after oral administration to a nonhuman primate.

Pajewski TN, Brabson JS, Kisic A, Wang KS, Hylarides MD, Jackson EM, Schroepfer GJ Jr.

Chem Phys Lipids. 1989 Mar;49(4):243-63.


Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

Wilbur DS, Hadley SW, Hylarides MD, Abrams PG, Beaumier PA, Morgan AC, Reno JM, Fritzberg AR.

J Nucl Med. 1989 Feb;30(2):216-26.


Structural comparison of 1-bromo- and 1-fluoroestradiol with D-estradiol.

Hylarides MD, Duesler EN, Mettler FA, Leon AA.

Acta Crystallogr C. 1988 Apr 15;44 ( Pt 4):709-12.


Endotoxin provocation of experimental renal cystic disease.

Gardner KD Jr, Reed WP, Evan AP, Zedalis J, Hylarides MD, Leon AA.

Kidney Int. 1987 Sep;32(3):329-34.


Preparation of B-ring brominated derivatives of estradiol.

Leon AA, Mettler FA, Hylarides MD.

Steroids. 1986 Nov-Dec;48(5-6):395-400.


Synthesis of 1-chloroestradiol.

Hylarides MD, Leon AA, Mettler FA.

Steroids. 1984 Feb;43(2):219-24.


B-ring aromatization of estrogen derivatives.

Hylarides MD, Wilbur DS, Mettler FA Jr.

Steroids. 1983 May;41(5):657-62.


Supplemental Content

Loading ...
Support Center